Determinants of serum ALT normalization after phlebotomy in patients with chronic hepatitis C infection

Journal of Gastroenterology

Volumn 40, Issue 9, 2005, Pages 901-906

  Kawamura, Yusuke ^a   Akuta, Norio ^a   Sezaki, Hitomi ^a   Hosaka, Tetsuya ^a   Someya, Takashi ^a   Kobayashi, Masahiro ^a   Suzuki, Fumitaka ^a   Suzuki, Yoshiyuki ^a   Saitoh, Satoshi ^a   Arase, Yasuji ^a   Ikeda, Kenji ^a   Kumada, Hiromitsu ^a  

^a TORANOMON HOSPITAL   (Japan)

Author keywords

ALT; HCV; Hepatocyte steatosis; Phlebotomy

Indexed keywords

ALANINE AMINOTRANSFERASE; FERRITIN; HEMOGLOBIN; NEOMINOPHAGEN C; URSODEOXYCHOLIC ACID;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER HISTOLOGY; MALE; MULTIVARIATE ANALYSIS; OBESITY; PHLEBOTOMY; PRIORITY JOURNAL; STEATOSIS; SURGICAL TECHNIQUE;

ADULT; AGED; ALANINE TRANSAMINASE; BIOLOGICAL MARKERS; DISEASE PROGRESSION; FEMALE; FERRITINS; FOLLOW-UP STUDIES; HEMOGLOBINS; HEPACIVIRUS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; PHLEBOTOMY; RETROSPECTIVE STUDIES; RNA, VIRAL; TREATMENT OUTCOME;

EID: 27244435206     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-005-1636-6     Document Type: Article

References (27)

1. LB Seeff 2002 Natural history of chronic hepatitis C Hepatology 36 5 Suppl 1 S35-46 10.1053/jhep.2002.36806 12407575
2. A Alberti L Chemello L Benvegnu 1999 Natural history of hepatitis C J Hepatol 31 Suppl 1 17-24 10.1016/S0168-8278(99)80369-9 10622555
3. S Iino 1998 Relationship between infection with hepatitis C virus and hepatocellular carcinoma in Japan Antivir Ther 3 Suppl 3 143-6 10726064
4. A Tsubota H Kumada Y Arase K Chayama S Saitoh K Ikeda et al. 1999 Combined ursodeoxycholic acid and glycyrrhizin therapy for chronic hepatitis C virus infection: A randomized controlled trial in 170 patients Eur J Gastroenterol Hepatol 11 1077-83 10524635
5. AM Di Bisceglie CA Axiotis JH Hoofnagle BR Bacon 1992 Measurements of iron status in patients with chronic hepatitis Gastroenterology 102 2108-13 1587431
6. T Takikawa H Hayashi N Nishimura M Yano T Isomura N Sakamoto 1994 Correlation between serum levels of alanine aminotransferase and ferritin in male blood donors with antibody to hepatitis C virus J Gastroenterol 29 593-7 8000507
7. J Kato M Kobune T Nakamura G Kuroiwa K Takada R Takimoto et al. 2001 Normalization of elevated hepatic 8-hydroxy-2′-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet Cancer Res 61 8697-702 11751387
8. VJ Desmet M Gerber JH Hoofnagle M Manna PJ Scheuer 1994 Classification of chronic hepatitis: Diagnosis, grading and staging Hepatology 19 1513-20 10.1016/0270-9139(94)90250-X 8188183
9. AM D'Alessandro M Kalayouglu HW Sollinger RM Hoffmann A Reed SJ Knechtle et al. 1991 The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation Transplantation 51 157-63 1987685
10. K Ikeda S Saitoh M Kobayashi Y Suzuki A Tsubota F Suzuki et al. 2000 Distinction between chronic hepatitis and liver cirrhosis in patients with hepatitis C virus infection. Practical discriminant function using common laboratory data Hepatol Res 18 252-66 10.1016/ S1386-6346(00)00074-7 11058829
11. M Hirayama Y Kohgo H Kondo N Shintani K Fujikawa K Sasaki et al. 1993 Regulation of iron metabolism in HepG2 cells: A possible role for cytokines in the hepatic deposition of iron Hepatology 18 874-80 8406363
12. H Zoller RO Koch I Theurl P Obrist A Pietrangelo G Montosi et al. 2001 Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overload Gastroenterology 120 1412-9 10.1053/gast.2001.24033 11313311
13. KC Cheng DS Cahill H Kasai S Nishimura LA Loeb 1992 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions J Biol Chem 267 166-72 1730583
14. T Oda H Tsuda A Scarpa M Sakamoto S Hirohashi 1992 p53 gene mutation spectrum in hepatocellular carcinoma Cancer Res 52 6358-64 1330291
15. H Hayashi T Takikawa N Nishimura M Yano T Isomura N Sakamoto 1994 Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron Am J Gastroenterol 89 986-8 8017395
16. A Piperno M Sampietro R D'Alba L Roffi S Fargion S Parma et al. 1996 Iron stores, response to alpha-interferon therapy, and effects of iron depletion in chronic hepatitis C Liver 16 248-54 8877995
17. DH Van Thiel L Friedlander PJ Molloy RJ Kania S Fagiuoli HI Wright et al. 1996 Retreatment of hepatitis C interferon nonresponders with larger doses of interferon with and without phlebotomy Hepatogastroenterology 43 1557-61 8975965
18. H Hayashi T Takikawa N Nishimura M Yano 1995 Serum aminotransferase levels as an indicator of the effectiveness of venesection for chronic hepatitis C J Hepatol 22 268-71 10.1016/0168-8278(95)80278-9 7608476
19. NC Tsai E Zuckerman SH Han K Goad AG Redeker TL Fong 1997 Effect of iron depletion on long-term response to interferon-alpha in patients with chronic hepatitis C who previously did not respond to interferon therapy Am J Gastroenterol 92 1831-4 9382046
20. TL Fong SH Han NC Tsai TR Morgan M Mizokami D Qian et al. 1998 A pilot randomized, controlled trial of the effect of iron depletion on long-term response to alpha-interferon in patients with chronic hepatitis C J Hepatol 28 369-74 10.1016/S0168-8278(98)80308-5 9551672
21. RJ Fontana J Israel P LeClair BF Banner K Tortorelli N Grace et al. 2000 Iron reduction before and during interferon therapy of chronic hepatitis C: Results of a multicenter, randomized, controlled trial Hepatology 31 730-6 10.1002/hep.510310325 10706565
22. AM Di Bisceglie HL Bonkovsky S Chopra S Flamm RK Reddy N Grace et al. 2000 Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: A multicenter, prospective, randomized, controlled trial Hepatology 32 135-8 10.1053/jhep.2000.8700 10869301
23. M Yano H Hayashi S Wakusawa F Sanae T Takikawa Y Shiono et al. 2002 Long term effects of phlebotomy on biochemical and histological parameters of chronic hepatitis C Am J Gastroenterol 97 133-7 10.1111/ j.1572-0241.2002.05436.x 11808937
24. S Fargion AL Fracanzani A Rossini M Borzio O Riggio G Belloni et al. 2002 Iron reduction and sustained response to interferon-alpha therapy in patients with chronic hepatitis C: Results of an Italian multicenter randomized study Am J Gastroenterol 97 1204-10 12014729
25. AJ Sanyal MJ Contos RK Sterling VA Luketic ML Shiffman RT Stravitz et al. 2003 Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome Am J Gastroenterol 98 2064-71 10.1111/j.1572-0241.2003.07640.x 14499789
26. DK George S Goldwurm GA MacDonald LL Cowley NI Walker PJ Ward et al. 1998 Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis Gastroenterology 114 311-8 9453491
27. A Riquelme A Soza L Nazal G Martinez M Kolbach A Patillo et al. 2004 Histological resolution of steatohepatitis after iron depletion Dig Dis Sci 49 1012-5 10.1023/B:DDAS.0000034564.68307.39 15309893